APA

Falchook G. S., Wheler J. J., Naing A., Piha-Paul S. A., Fu S., Tsimberidou A. M., Hong D. S., Janku F., Zinner R., Jiang Y., Huang M., Lin Q., Parkhurst K. & Kurzrock R. (20150918). Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. : Investigational new drugs.

Chicago

Falchook Gerald S, Wheler Jennifer J, Naing Aung, Piha-Paul Sarina A, Fu Siqing, Tsimberidou Apostolia M, Hong David S, Janku Filip, Zinner Ralph, Jiang Yunfang, Huang Mei, Lin Quan, Parkhurst Kristin and Kurzrock Razelle. 20150918. Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. : Investigational new drugs.

Harvard

Falchook G. S., Wheler J. J., Naing A., Piha-Paul S. A., Fu S., Tsimberidou A. M., Hong D. S., Janku F., Zinner R., Jiang Y., Huang M., Lin Q., Parkhurst K. and Kurzrock R. (20150918). Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. : Investigational new drugs.

MLA

Falchook Gerald S, Wheler Jennifer J, Naing Aung, Piha-Paul Sarina A, Fu Siqing, Tsimberidou Apostolia M, Hong David S, Janku Filip, Zinner Ralph, Jiang Yunfang, Huang Mei, Lin Quan, Parkhurst Kristin and Kurzrock Razelle. Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. : Investigational new drugs. 20150918.